Literature DB >> 1779033

Obstructive sleep apnea syndrome: pathogenesis of neuropsychological deficits.

M A Bédard1, J Montplaisir, F Richer, I Rouleau, J Malo.   

Abstract

Neuropsychological deficits have been documented in patients with obstructive sleep apnea syndrome (OSAS). Both nocturnal hypoxemia and impairement of daytime vigilance have been suggested as the pathogenesis of these deficits, yet it remains difficult to find good correlations between cognitive deficits and either of these physiological parameters. In the present study, 10 normal controls were compared to 10 moderately and 10 severely apneic patients, all recorded in a sleep laboratory for two consecutive nights, with a vigilance and neuropsychological assessment made during the intervening day. Relative to the controls, moderate and severe OSAS showed differences in many cognitive functions, although the severely affected showed the greater differences. Moreover, severe apneics were also worse than moderate apneics on tests that were found to be normal in the latter group. This suggests a discontinuity in the appearance of neuropsychological deficits as OSAS progresses. Further analyses revealed that reductions in general intellectual measures, as well as in executive and psychomotor tasks were all attributable to the severity of hypoxemia, while other attention and memory deficits were related to vigiance impairment. Therefore, both vigilance impairment and nocturnal hypoxemia may differentially contribute to the cognitive dysfunctions found in OSAS.

Entities:  

Mesh:

Year:  1991        PMID: 1779033     DOI: 10.1080/01688639108405110

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  66 in total

Review 1.  Sleep. 4: Sleepiness, cognitive function, and quality of life in obstructive sleep apnoea/hypopnoea syndrome.

Authors:  H M Engleman; N J Douglas
Journal:  Thorax       Date:  2004-07       Impact factor: 9.139

Review 2.  Sleep . 8: paediatric obstructive sleep apnoea.

Authors:  G M Nixon; R T Brouillette
Journal:  Thorax       Date:  2005-06       Impact factor: 9.139

Review 3.  Neuropsychological functioning associated with high-altitude exposure.

Authors:  Javier Virués-Ortega; Gualberto Buela-Casal; Eduardo Garrido; Bernardino Alcázar
Journal:  Neuropsychol Rev       Date:  2004-12       Impact factor: 7.444

4.  Sleep and Cognitive Function in Multiple Sclerosis.

Authors:  Tiffany J Braley; Anna L Kratz; Neeraj Kaplish; Ronald D Chervin
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

5.  High rates of obstructive sleep apnea symptoms among patients with schizophrenia.

Authors:  Aniyizhai Annamalai; Laura B Palmese; Lydia A Chwastiak; Vinod H Srihari; Cenk Tek
Journal:  Psychosomatics       Date:  2014-03-02       Impact factor: 2.386

6.  Working memory in obstructive sleep apnea: construct validity and treatment effects.

Authors:  Joshua C Felver-Gant; Amanda S Bruce; Molly Zimmerman; Lawrence H Sweet; Richard P Millman; Mark S Aloia
Journal:  J Clin Sleep Med       Date:  2007-10-15       Impact factor: 4.062

7.  Caffeine intake is independently associated with neuropsychological performance in patients with obstructive sleep apnea.

Authors:  Daniel Norman; Wayne A Bardwell; Jose S Loredo; Sonia Ancoli-Israel; Robert K Heaton; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2008-08       Impact factor: 2.816

8.  Relationship between obstructive sleep apnea severity and brain activation during a sustained attention task.

Authors:  Liat Ayalon; Sonia Ancoli-Israel; Allison A Aka; Benjamin S McKenna; Sean P A Drummond
Journal:  Sleep       Date:  2009-03       Impact factor: 5.849

9.  Gunshot wound to the head: an unusual complication of sleep apnea and bilevel positive airway pressure.

Authors:  John Baron; Dennis Auckley
Journal:  Sleep Breath       Date:  2004-09       Impact factor: 2.816

10.  Neural alterations associated with anxiety symptoms in obstructive sleep apnea syndrome.

Authors:  Rajesh Kumar; Paul M Macey; Rebecca L Cross; Mary A Woo; Frisca L Yan-Go; Ronald M Harper
Journal:  Depress Anxiety       Date:  2009       Impact factor: 6.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.